CADILA HEALTHCARE share price has zoomed 5% and is presently trading at Rs 349.
Meanwhile, the BSE HEALTHCARE Index is at 14,300 (up 0.3%).
Among the top Gainers in the BSE HEALTHCARE Index today is CADILA HEALTHCARE (up 5.0%).
FORTIS HEALTHCARE (down 0.1%) and TORRENT PHARMA (down 0.1%) are among the top losers today.
Over the last one year, CADILA HEALTHCARE has moved down from Rs 388 to Rs 349, registering a loss of Rs 39 (down 10.6%).
On the other hand, the BSE HEALTHCARE has moved up from 13,700 to 14,300, registering a gain of 600 points (up 4.0%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were DIVIS LABORATORIES (up 61.5%), SUVEN LIFESCIENCES (up 43.5%) and PFIZER (up 43.4%).
What About the Benchmark Indices?
The BSE Sensex is at 38,105 (up 0.9%).
The top gainers among the BSE Sensex stocks today are TCS (up 3.5%), POWER GRID (up 2.8%) and WIPRO (up 2.1%). Other gainers include SBI (up 1.9%) and INFOSYS (up 1.8%). The most traded stocks in the BSE Sensex are SBI and ICICI BANK.
In the meantime, NSE Nifty is at 11,452 (up 0.9%). KOTAK MAHINDRA BANK (up 4.7%) is among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 33,836 to 38,105, registering a gain of 4,269 points (up 12.6%).
CADILA HEALTHCARE Financial Update…
CADILA HEALTHCARE net profit down at Rs 5 billion for the quarter ended December 2018, compared to a loss of Rs 5 billion a year ago. Net Sales rose 9.8% to Rs 35.8 billion during the period as against Rs 32.6 billion in October-December 2017.
For the year ended March 2018, CADILA HEALTHCARE reported 18.9% increase in net profit to Rs 17.7 billion compared to net profit of Rs 14.9 billion during FY17.
Revenue of the company grew 24.7% to Rs 119 billion during FY18.
The current Price to earnings ratio of CADILA HEALTHCARE, based on rolling 12 month earnings, stands at 18.1x. p >
This article (CADILA HEALTHCARE Surges by 5%; BSE HEALTHCARE Index Up 0.3%) is authored by Equitymaster.